Par Pharmaceutical: High-Quality, Cost-Effective Generic Products

Par Pharmaceutical, headquartered in Chestnut Ridge, New York, develops, manufactures and markets safe, innovative and cost-effective generic pharmaceutical products that help improve patient quality of life. Par, among the top four leaders in the U.S. generics industry, possesses a portfolio that includes sterile injectables, alternative dosage forms and many other differentiated products. Par is advancing a research and development (R&D) pipeline of more than 200 potential new products.  Par is an operating company of Endo International plc, a highly focused generics and specialty branded pharmaceutical company delivering quality medicines to patients through excellence in development, manufacturing and commercialization. 

Learn More at ParPharm.com

About UsEndo Pharmaceuticals - Product Pipeline

Learn more about Par Pharmaceutical’s history, mission, facilities and commitment to compliance and quality.

Learn more

Current Market Products

Endo Pharmaceuticals - Market Products

Our generic-drug portfolio consists of numerous products across a wide range of therapeutic areas that are the therapeutic equivalent of the brand-name pharmaceuticals.

Learn more